A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
Volunteers
Health Professionals
What is the purpose of this trial?
This clinical trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Alessandro Santin, MD
- Beverly Drucker, MD, PhD
- Blair Colette McNamara, MD
- Christi Kim, MD, FACP
- Elena Ratner, MD, MBA
- Gary Altwerger, MD
- Jamie Malette
- Levent Mutlu, MD
- Martha Diaz
- Masoud Azodi, MD
- Megin Iaccarino
- Mitchell Clark, MD, MPH
- Natalia Buza, MD
- Nesrine Khoury
- Pei Hui, PhD, MD
- Peter Dottino, MD, FACOG
- Peter Schwartz, MD
- Robert Legare, MD
- Shari Damast, MD
- Stephen Lattanzi, MD
- Vaagn Andikyan, MD
- Last Updated04/11/2024
- Study HIC#2000031409